Scottish startup Waire Health has received £2m from Eos Advisory in a funding round for the scaling of its remote patient monitoring technology, C-Detect, which is designed to enhance remote ward monitoring and lower hospital readmissions. The round of funding was secured alongside Scottish Enterprise. Waire Health will use the funding to expand its management team, production and product development capabilities, as well as boost expansion in worldwide markets, including North America. The company’s C-Detect remote patient monitoring device can be used in hospitals and homes autonomously. C-Detect is anticipated to cut down costs and enhance outcomes through continuous real-time monitoring and advanced artificial intelligence (AI). Developed at the company’s Dunfermline headquarters, C-Detect is produced at a facility near Edinburgh. With support from the University of California and organisations that include global healthcare organisations and national governments, Waire Health has extensively tested its device in trials. Waire Health CEO and founder Dave Hurhangee said: “The whole area of care at home got pushed over the edge during Covid. What many companies didn’t fully appreciate was the paramount importance of usability. “If devices have to rely on mobile connections or Bluetooth, they become difficult to use from the outset, for both patients and healthcare providers.” The company also collaborated with the Irish Government and India-based Tata Group on a pilot study related to the technology. Eos Advisory partner Mark Beaumont said: “As healthcare systems in the UK and around the world move to remote monitoring and real-time patient data, we see a huge opportunity for Waire Health to scale its C-Detect device.” The post Waire Health raises funds for remote patient monitoring technology appeared first on Medical Device Network. Waire Health raises funds for remote patient monitoring technology syndicated from medsurgicalsupplies.wordpress.com
0 Comments
“We are delighted to partner with the leading predictive intelligence technology on the market today for companies wanting to identify the segments, teams, and individuals at risk so that leaders - at all levels - can be empowered to understand and address the compounding effects of work and life stressors on the performance, retention, and wellbeing of their workforce,” said Jason Walker, co-founder of Thrive HR Consulting.
Thrive HR Partners with OrgVitals to Deliver a New Gold Standard in Employee Experience syndicated from medsurgicalsupplies.wordpress.com
Ibex's Galen™ Breast HER2 is an IHC scoring product that detects tumor areas and quantifies HER2 expression into four standard categories, 0, 1+, 2+ and 3+, based on the 2018 ASCO/CAP scoring guidelines
Ibex Medical Analytics Enters Collaboration with AstraZeneca and Daiichi Sankyo to Develop AI-based HER2 Scoring Product syndicated from medsurgicalsupplies.wordpress.com
The BioVentrix Revivent TC System is designed to support a minimally invasive procedure to treat a dilated left ventricle of patients with ischemic heart failure with reduced ejection fraction (HFrEF) and extensive left ventricular scar, who have a suboptimal response to guideline-directed medical therapy.
FDA Agrees to Expanded Access Program for the BioVentrix® Revivent TC System for the Treatment of Ischemic Heart Failure syndicated from medsurgicalsupplies.wordpress.com
Amber-UI is the first fully implantable closed-loop bioelectrical therapy in clinical development for UI, which is made possible by being able to access and target the pudendal nerve – the nerve that directly controls continence – through a novel, minimally invasive surgical procedure.
Amber Therapeutics Announces Successful First-in-human Implants of Amber-UI: An Intelligent, Closed-loop Bioelectrical Therapy for Urge and Mixed Urinary Incontinence syndicated from medsurgicalsupplies.wordpress.com NeuroMetrix has commercially launched its new DPNCheck 2.0 point-of-care device for detecting peripheral neuropathy. The new quick, accurate, quantitative test uses nerve conduction technology to detect peripheral neuropathy, the systemic degeneration of peripheral nerves. It offers rapid patient screening through quantitative peripheral nerve function measurement. DPNCheck can be used to assess systemic neuropathies that include diabetic peripheral neuropathy (DPN). It is intended for point-of-care use by clinicians to accurately detect, stage and monitor peripheral neuropathies. The device includes step-by-step onboarding instructions, a real-time nerve response display, an easy-to-use touchscreen, improved temperature compensation and other enhancements. Furthermore, DPNCheck’s companion software enables clinical documentation of test results. The company is planning cloud-based population-health data aggregation as well as integration with provider electronic health record (EHR) systems later in the year. NeuroMetrix CEO Shai Gozani said: “For more than a decade, our first-generation DPNCheck device has been used and trusted by thousands of providers to assess over two-million patients. “We are excited to launch our newest version to even better address the needs of our clinical partners. “We’ve opened the door to more widespread screening with a user-friendly design that makes it faster and easier for care organisations to roll out and train their point-of-care staff and deploy testing.” The company stated that its new nerve conduction test enables the potential uncovering of elevated risk for peripheral neuropathy complications. This allows such complications to be identified earlier and more accurately compared to traditional clinical methods, which include the monofilament and tuning fork tests. The post NeuroMetrix launches peripheral neuropathy test DPNCheck 2.0 appeared first on Medical Device Network. NeuroMetrix launches peripheral neuropathy test DPNCheck 2.0 syndicated from medsurgicalsupplies.wordpress.com
Ensuring that medical staff in your clinic have the proper training and education is essential for providing quality healthcare to patients. It is important to ensure that all of your medical staff have the necessary skills and knowledge in order to provide safe and effective treatments, while also staying up-to-date with new developments in the […]
Importance of Medical Training for Your Clinic syndicated from medsurgicalsupplies.wordpress.com Asensus Surgical has obtained CE mark for the expanded machine vision capabilities on its previously cleared Intelligent Surgical Unit (ISU). This regulatory approval makes the expanded ISU capabilities available across Japan, the European Union (EU) and the US. In September 2021, the US Food and Drug Administration (FDA) granted 510(k) clearance for the expanded machine vision capabilities. The latest approval also covers a review of the Senhance Surgical System platform, which makes it one of the first surgical robotic systems approved through the latest EU Medical Device Regulation (MDR) process. The expanded capabilities of the ISU include image enhancement, digital tagging, 3D measurement and enhanced camera control based on real-time data from anatomical structures during surgery. Asensus Surgical president and CEO Anthony Fernando said: “We are thrilled to be able to offer these ground-breaking ISU capabilities to surgeons in the EU. “Surgeon feedback from the expanded feature set across the US and Japan has been tremendous, and we look forward to partnering with new and existing customers to help bring advanced real-time intraoperative digital tools into operating rooms throughout Europe. “This is a significant milestone for the Company as our filing included a review of the Senhance Surgical System, both software and hardware, under the new, stricter EU MDR process.” The company believes that the expanded augmented intelligence features approval will offer better support for surgeons across several specialities and procedures. It also expects that the foundational elements of the features will allow it to use the ISU’s capabilities and potential to introduce further augmented features in the future. The post Asensus Surgical obtains CE mark for ISU’s expanded capabilities appeared first on Medical Device Network. Asensus Surgical obtains CE mark for ISU’s expanded capabilities syndicated from medsurgicalsupplies.wordpress.com Supply chain breakdowns in medical device companies are becoming increasingly common. With the ever-evolving complexity of design and development processes, medical device developers are progressively vulnerable. From supply chain vulnerability medical supply shortages to supply chain vulnerabilities, companies should take proactive measures to mitigate the risk of disruption in their supply chains. Fortunately, there are several strategies that manufacturers can employ to avoid holes in their supply chain and ensure a reliable and efficient medical product supply chain management process. 1. Adopt agile development strategies:By utilizing agile development strategies, medical device companies can quickly adjust to changing critical supply needs and medical device supply chain vulnerabilities. This allows medical device manufacturers to reduce risk associated with supply chain challenges, as well as create a more flexible and responsive organization overall. By utilizing agile development strategies such as short design cycles, real-time feedback, and reducing the overall design time frame, companies are better equipped to address volatility in the medical device supply chain and can more easily adjust to an ever-evolving marketplace. 2. Manage potential material supply disruption:Medical device companies should incorporate mindful design and development initiatives to prevent any potential material supply disruptions from wreaking havoc on the design process. Good design and development processes are essential for medical device design but managing potential material supply disruption during this process shouldn’t be overlooked. A strong inventory of materials is key to mitigating supply chain interruptions down the road. Designers should use first-hand market insight to proactively evaluate the origin and viability of each supplier’s parts. Designing medical devices is a complex and challenging endeavor, and it’s critical to consider how design decisions may impact the product supply chain. With this proactive approach, design teams can create robust plans that anticipate potential issues, adjust design parameters if necessary, and proactively manage risks before they cause costly delays or worse. By putting thoughtful measures in place throughout the design process, design teams can equip themselves with the tools needed to ensure a successful product launch without supply chain vulnerability. 3. Supply chain risk mitigation during design:Medical device manufacturers should develop comprehensive plans that identify medical supply chain risks and vulnerabilities, as well as provide strategies for managing risk. Risk management is a critical element of the development process for creating successful medical devices. Medical device delays can pose a significant risk to the supply chain due to production issues, delays, cost overruns, and quality control issues. Successfully navigating this design process requires an in-depth knowledge of design principles along with comprehensive product life cycle and supplier management techniques to mitigate such risks. Additionally, incorporating risk management procedures into the design and development process can help ensure that relevant regulatory requirements are considered. As a result, medical device companies can protect their supply chains from potential disruption and stay better prepared for market unpredictability. 4. Device re-design:With resources already drained from potential supply chain interruption, companies may need to explore a project re-design. This process is often susceptible to several elements including technology, cost structure changes, and design impacts, and should be done with careful consideration. Companies looking to reduce risk factors should discuss mitigation strategies with supply chain partners to better understand the right approach for any design and re-design initiatives. Re-designing processes to combat disruptions can be a daunting process with many costly implications. Streamlining design and development involves extensive work and careful planning to ensure that components come together seamlessly. But re-design teams can craft a path forward that maximizes cost savings and meets safety and regulatory requirements. While tackling supply chain disruption requires dedication, research, and experience, it can be accomplished successfully with the right resources – allowing for optimized design, improved delivery times, and, ultimately, decreased costs. 5. Supplier and inventory management:The development of medical devices entails a plethora of complexities, and supply chain disruption is one such obstacle that impacts every step of these processes. The burden of ensuring timely delivery, inventory control, and precisely forecasting supplier demand can be overwhelming for most businesses, especially those in the medical device space. To remain competitive in this intensely volatile market, having a supply chain and inventory management strategy is crucial. However, it’s often difficult to design risk strategies that will protect the company from destabilization due to unexpected supply chain disruptions. Businesses should take corrective steps immediately to identify any areas that are vulnerable within their end-to-end supply chain and quickly design solutions with minimum delays and cost implications. Medical device supply chains are at a greater risk of disruption than ever before. By implementing agile design strategies and proactively managing materials, design risk can be mitigated, and potential issues averted. Device re-design in the design stage can help to prevent any lapses in material availability or supplier performance. Inventory and supplier management are also key elements of avoiding any holes in the supply chain. With these proactive measures in place, organizations may have a much better chance of producing devices on time with little to no disruption. Learn more about our medical devices product development services or contact us for a development consultation. The post Avoid Medical Device’s Supply Chain Vulnerabilities with These Five Tips appeared first on Sterling Medical Devices. Avoid Medical Device’s Supply Chain Vulnerabilities with These Five Tips syndicated from medsurgicalsupplies.wordpress.com
What is Dementia? Dementia is a broad term used to describe a decline in cognitive function. It can affect memory, thinking, language, and judgment. Dementia is not a normal part of aging, and it is not reversible. There are many different causes of dementia, including Alzheimer’s disease, Lewy body disease, frontotemporal dementia, and vascular dementia. Symptoms […]
In-Home Care vs. Dementia Care Facility: Which Is Right for Your Loved One? syndicated from medsurgicalsupplies.wordpress.com |
About UsWe will help you to explore everything you need to know about meditation, whether you are looking to start your own personal meditation practice, meditating a long time, or are simply exploring the topic. I will explain you the simple art of meditation, describe different techniques used around the world, and help you to find what works for you. |